XponentL Data’s Post

Collaboration is a key component of medical innovation. We proudly partner with health research organizations and pharmaceutical companies who share our core values and are dedicated to driving science and technology forward. Discover how we can work together to transform healthcare: https://lnkd.in/eXqkjzGr #clinicalphenotyping #research #clinicalstudies #PGx #pharmacogenomics

I had the privilege of attending the international conference at SMBT College of Pharmacy on 05 &06th of january, where the theme centered around the Integration of Artificial Intelligence and Traditional Medicine in Drug Design. It was truly inspiring to witness groundbreaking discussions and presentations on this frontier of pharmaceutical innovation. From exploring AI-driven drug discovery to leveraging traditional medicine's insights, the conference provided invaluable insights into the future of healthcare. Grateful to the organizers and speakers for such a enlightening experience! #PharmaceuticalInnovation #AIIntegration #SMBTConference"

We’re passionate about helping pharmaceutical companies better understand patient experiences and enhance product differentiation through prospective real-world generation strategies. Find out more in this Xtalks Spotlight Interview with Pack Health’s Kelly Brassil, PhD. The discussion dives into current challenges in real-world evidence generation, how prospective data collection and patient experience studies can generate deep insights, and strategies for building an evidence generation strategy customized to your needs.  Check out the Xtalks Spotlight Interview: https://lnkd.in/gPYTdd4V

Important for beginners to learn Computer Aided Drug Design and Discovery methods.

📢 [Point of View] A Dose of Digital: Can Pharma Make Digital Therapeutics a Healthy Business? A new point of view by Ipsos explores the complex world of digital therapeutics (DTx). As pharmaceutical companies increasingly strive to integrate digital therapeutics into their strategies, they encounter challenges in navigating regulatory uncertainty and slow adoption rates. The authors, Francine Fram and Svetlana Gogolina, share a 5-stage framework for developing resilient and scalable digital therapeutics businesses. Read the full article here: https://lnkd.in/eHDEWY-K #DigitalTherapeutics #DTx  #HealthcareInnovation #PharmaStrategy

📢 [Point of View] A Dose of Digital: Can Pharma Make Digital Therapeutics a Healthy Business? A new point of view by Ipsos explores the complex world of digital therapeutics (DTx). As pharmaceutical companies increasingly strive to integrate digital therapeutics into their strategies, they encounter challenges in navigating regulatory uncertainty and slow adoption rates. The authors, Francine Fram and Svetlana Gogolina, share a 5-stage framework for developing resilient and scalable digital therapeutics businesses. Read the full article here: https://lnkd.in/emEh8-PT #DigitalTherapeutics #DTx  #HealthcareInnovation #PharmaStrategy

🌟 Join Circuit Clinical for an enlightening webinar series on enhancing participant representation in research through community-based clinical trials! 💡 The first webinar in the series explores Circuit Clinical’s Community Research Network and the impact of community #healthcare on accelerating drug development and medical innovation. 🎤 Featured speakers will delve into: ➔ The significance of community-based research in the pharmaceutical landscape ➔ How community-based research sites differ from traditional models ➔ Challenges and considerations for pharmaceutical sponsors and CROs ➔ Factors to weigh when selecting a community research site 🔗 REGISTER HERE: https://buff.ly/3uP4XEq ⭐ Featured speakers: Alaina Anderson, MBA Elizabeth Seyfert Laura Warwick #DrugDevelopment #ClinicalResearch #PatientRecruitment #ClinicalSites #PatientParticipation

🌟 Exploring Drug Efficacy with Quantitative Surveys 🌟 Dive into our latest carousel to see how leveraging quantitative market research for clinicians' and patients' feedback on drug efficacy is crucial in shaping effective treatments. From pinpointing patient responses to optimizing drug formulations, this research provides the insights necessary for groundbreaking advancements in healthcare. Swipe through to uncover the power of data in pharmaceutical research! 🔗 Learn more about our research methods and their impact at www.grgonline.com #DrugDevelopment #PatientCare #HealthcareData #ClinicalResearch #PharmaInnovation #GRGHealth

Watch the panel discussion on ‘Advances in Drug Discovery & Development 2024’ by Technology Networks in conversation with Clarivate experts - Matthew Arnold and Mike Ward - along with Hong I. Wan, CEO and Founder of Tallac Therapeutics, in the Clarivate Companies to Watch report. Gain insights on: ➡️ The history of ADC development, highlighting the challenges pharma companies face across the development and commercialization lifecycle and what they should consider when acquiring and using ADCs. ➡️ Current clinical activity and dealmaking in the ADC space, reflecting the growing maturity of ADC technologies. ➡️ The regulatory environment around ADCs and how it differs across key markets. ➡️ The challenges pharma companies face in developing linker technology. ➡️ What the next generation of ADCs will look like and their potential to address unmet therapeutic needs. View here: https://lnkd.in/eKMKKHWM #DrugDiscovery #Pharmaceuticals #ADCs #Regulatory #HealthcareLeadership

Check out our latest paper on DTx. We talk about the challenges but more importantly how you can build a solid foundation for success! #digitaltherapeutics #healthcare #digital